Skip to content

Automated Video-Assisted Smoking Treatment for People Living With HIV

Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living With HIV (Project RESOURCE)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05014282
Enrollment
638
Registered
2021-08-20
Start date
2021-12-15
Completion date
2026-09-23
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Brief summary

This study will evaluate if Automated Treatment performs better, in terms of facilitating long-term smoking abstinence, than the more resource-intensive Standard Treatment.

Interventions

DRUGNicotine patch

Participants will be provided with a 10-week supply of nicotine patches

BEHAVIORALCounseling

Phone counseling with the state tobacco quitline.

DRUGNicotine lozenge

Participants will be provided with a 10-week supply of nicotine lozenges

An interactive smartphone-based intervention that comprises content delivered via audio/video clips and text content automatically each week to the participant

Sponsors

H. Lee Moffitt Cancer Center and Research Institute
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* smoked \>/=100 cigarettes in lifetime * English or Spanish speaking * Currently smoke \> 5 cigarettes/day * Willing to make a quit attempt within 1 week of enrollment * HIV positive * Process a smartphone compatible with the project app * Have a valid email address

Exclusion criteria

* Currently pregnant or breastfeeding * Current use of smoking cessation medications * Enrolled in a smoking cessation study * Household member enrolled in the study * Failure to electronically confirm participation within 14 days of randomization via electronic link sent to participant's smartphone

Design outcomes

Primary

MeasureTime frameDescription
Self Reported 7 Day Abstinence Smoking Status12 Month Follow-UpParticipants will self report 7-day abstinence smoking status

Secondary

MeasureTime frameDescription
Smoking Status by Saliva Cotinine Kit12 Month Follow-UpInvestigators will verify smoking status by collecting cotinine sample from a saliva cotinine kit.
Self Reported 24 Hours Smoking Abstinence12 Month Follow-UpNumber of participants who report they quit smoking for 24 hours
30 Day Smoking Abstinence12 Month Follow-UpNumber of participants who report they quit smoking for 30 days
Continuous Smoking Abstinence12 Month Follow-UpNumber of participants who report they quit smoking

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDamon J Vidrine, Dr.PH

Moffitt Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026